Abstract
Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In placebo-controlled clinical studies, lamotrigine has been shown to be effective in reducing seizure frequency and the number of days with seizures when added to existing antiepileptic drug therapy in adult patients with partial seizures, with or without generalized tonic-clonic seizures, that are not satisfactorily controlled. Lamotrigine has emerged as a first line treatment for bipolar depression, which is an area of weakness for other mood stabilizers, with positive effect for resistant bipolar disorders and rapid cycling bipolar disorders. We review the Literature on the topic with a specific interest on bipolar disorders.
Keywords: Antiepileptic drugs, Bipolar depression, DSM-IV, double-blind maintenance, randomized controlled trials
Letters in Drug Design & Discovery
Title: Lamotrigine as an Effective Treatment for Behavioral Disorders
Volume: 4 Issue: 6
Author(s): Rita Moretti, Paola Torre, Cristina Vilotti and Rodolfo M. Antonello
Affiliation:
Keywords: Antiepileptic drugs, Bipolar depression, DSM-IV, double-blind maintenance, randomized controlled trials
Abstract: Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In placebo-controlled clinical studies, lamotrigine has been shown to be effective in reducing seizure frequency and the number of days with seizures when added to existing antiepileptic drug therapy in adult patients with partial seizures, with or without generalized tonic-clonic seizures, that are not satisfactorily controlled. Lamotrigine has emerged as a first line treatment for bipolar depression, which is an area of weakness for other mood stabilizers, with positive effect for resistant bipolar disorders and rapid cycling bipolar disorders. We review the Literature on the topic with a specific interest on bipolar disorders.
Export Options
About this article
Cite this article as:
Rita Moretti , Paola Torre , Cristina Vilotti and Rodolfo M. Antonello , Lamotrigine as an Effective Treatment for Behavioral Disorders, Letters in Drug Design & Discovery 2007; 4 (6) . https://dx.doi.org/10.2174/157018007781387836
DOI https://dx.doi.org/10.2174/157018007781387836 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: New Ligands at 5-HT and DA Receptors for the Treatment of Neuropsychiatric Disorders (Guest Editor: Giuseppe Di Giovanni) ]
Current Topics in Medicinal Chemistry Medical Technology: A Systematic Review on Medical Devices Utilized for Epilepsy Prediction and Management
Current Neuropharmacology Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity
Current Topics in Medicinal Chemistry Review of the Biological Activity of Maslinic Acid
Current Drug Targets Astrocytic Target Mechanisms in Epilepsy
Current Medicinal Chemistry Patent Selections:
Recent Patents on Biotechnology Assessing Glutamatergic Function and Dysfunction in Peripheral Tissues
Current Medicinal Chemistry Genetics and Genomics of Hepatic Acute Phase Reactants: A Mini-Review
Inflammation & Allergy - Drug Targets (Discontinued) QSAR Studies for the Pharmacological Inhibition of Glycogen Synthase Kinase-3
Medicinal Chemistry Inhibition of Monoamine Neurotransmitter Transporters andCentral Nervous System Stimulation Induced by Synthetic Local Anesthetics and Cocaine: A Comparative Review
Current Medicinal Chemistry - Central Nervous System Agents Molecular Docking Study, Green Synthesis and Pharmacological Evaluation of 1,3,4-thiadiazole Derivatives as Potential Antiepileptic Agents
Mini-Reviews in Medicinal Chemistry Physiological and Pharmacological Insights into the Role of Ionic Channels in Cardiac Pacemaker Activity
Cardiovascular & Hematological Disorders-Drug Targets Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Drugs from the Sea: Conopeptides as Potential Therapeutics
Current Medicinal Chemistry Development, Recent Achievements and Current Directions of Research into GABA Uptake Inhibitors
Current Medicinal Chemistry Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Does the Vitamin D Deficiency Have Any Role in Severity or Prolongation of Seizure? A Pilot Study in Iran
Current Nutrition & Food Science Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
Current Neuropharmacology Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Current Gene Therapy The Role of Calcium Stores in Apoptosis and Autophagy
Current Molecular Medicine